SCHEMBL23555541

SCHEMBL23555541

Cc1nc2cc(Br)c(O)cc2c(=O)n1Cc1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ KDM4E B2RXH2 4/20 0.62
▸ HSD17B10 Q99714 2/20 0.62
▸ HPGD P15428 1/20 0.62
▸ LMNA P02545 3/20 0.58
▸ HDAC1 Q13547 2/20 0.58
▸ HDAC2 Q92769 2/20 0.58
▸ HDAC11 Q96DB2 2/20 0.58
▸ HDAC8 Q9BY41 2/20 0.58
▸ HDAC6 Q9UBN7 2/20 0.58
▸ NPC1 O15118 2/20 0.58
▸ HDAC3 O15379 1/20 0.58
▸ HDAC4 P56524 1/20 0.58
▸ HDAC7 Q8WUI4 1/20 0.58
▸ HDAC10 Q969S8 1/20 0.58
▸ HDAC9 Q9UKV0 1/20 0.58
▸ HDAC5 Q9UQL6 1/20 0.58
▸ MEN1 O00255 5/20 0.57
▸ KMT2A Q03164 5/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23555538 0.88 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555539 0.86 MEN1 (0.47) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555540 0.84 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555535 0.84 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555767 0.78 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555769 0.76 KDM4E (0.55) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL31196722 0.75 SMN1; SMN2 (0.70) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555526 0.74 SRC (0.47) HDAC1HDAC8HDAC6KMT2A
SCHEMBL31196725 0.74 SMN1; SMN2 (0.70) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL1882530 0.74 SMN1; SMN2 (0.62) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127071-A1 BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES MERCK SHARP & DOHME CORP. (US) 2021-06-24 — — WO disclosed
Send feedback